JCR Pharmaceuticals Co Ltd (4552) Stock Price & News

Why is 4552 up 2.49%?

Dive Deeper

4552:TYO

JCR Pharmaceuticals Co Ltd

¥536.00

+2.49%

(+13.00) 1D

Oct 15, 3:30:00 PM GMT+9 · JPY

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 4552...

Open

¥525

High

¥544

Low

¥522

Mkt. cap

69.51B

Avg. vol.

753.60K

Volume

1.58M

Dividend

3.73%

Quarterly dividend

¥5

Ex-dividend date

Sep 29, 2026

P/E ratio

79.94

52-wk high

¥824

52-wk low

¥444

EPS

¥7

Shares outstanding

30.79M

No. of employees

985

Open

¥525

High

¥544

Low

¥522

Mkt. cap

69.51B

Avg. vol.

753.60K

Volume

1.58M

Dividend

3.73%

Quarterly dividend

¥5

Ex-dividend date

Sep 29, 2026

P/E ratio

79.94

52-wk high

¥824

52-wk low

¥444

EPS

¥7

Shares outstanding

30.79M

No. of employees

985

Related stocks

4568

Daiichi Sankyo Co Ltd

¥2,651.00

+1.92%

4502

Takeda Pharmaceutical Co Ltd

Sumitomo Pharma Co Ltd

¥1,842.00

+15.81%

News stories

From web sources and news partners

TradingView

55 minutes ago

TruGolf Holdings (NASDAQ: TRUG) Taps Newly Acquired Polymath to Tokenize Franchise Ownership Records

Yahoo Finance

1 hour ago

Dr. Calvin Choi on TGE's NYSE Listing and Global SPAC Strategy

Reuters

11 minutes ago

Nasdaq reports network disruption, US equities data feeds impacted

CNN

5 hours ago

Global tech sell-off deepens as enthusiasm for AI stocks wobbles

About JCR Pharmaceuticals Co Ltd

CEO-

Employees985

FoundedSep 13, 1975

Headquarters-

SectorPharmaceutical industry

Websitejcrpharm.co.jp

All values in JPY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	12.79B	8.99B	9.97B	9.70B
Cost of goods sold	1.92B	2.39B	3.42B	2.25B
Cost of revenue	1.92B	2.39B	3.42B	2.25B
Research and development expenses	-	-	16.76B	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	7.84B	8.50B	-10.29B	9.55B
Operating expense	7.88B	8.54B	6.48B	9.55B
Total operating expenses	9.80B	10.93B	9.90B	11.80B
Operating income	3.00B	-1.94B	66.00M	-2.10B
Other non operating income	34.00M	49.00M	-65.00M	135.00M
EBT including unusual items	3.34B	281.00M	402.00M	-2.08B
EBT excluding unusual items	3.12B	-1.64B	28.00M	-2.08B
Income tax expense	1.03B	157.00M	27.00M	-166.00M
Effective tax rate	30.79%	55.87%	6.72%	7.97%
Other operating expenses	-	-	-	-
Net income	2.29B	69.00M	399.00M	-1.91B
Net profit margin	17.92%	0.77%	4.00%	-19.66%
Earnings per share	-	-	-	-
Interest and investment income	30.00M	33.00M	27.00M	23.00M
Interest expense	-78.00M	-151.00M	-90.00M	-157.00M
Net interest expenses	-48.00M	-118.00M	-63.00M	-134.00M
Depreciation and amortization charges	39.00M	36.00M	12.00M	-
EBITDA	3.73B	-1.09B	705.25M	-1.46B
Gain or loss from assets sale	-	-	-	-

Ask anything